GoviEx Uranium (CVE:GXU) Given a C$0.81 Price Target by Fundamental Research Analysts

GoviEx Uranium (CVE:GXU – Get Rating) has been assigned a C$0.81 target price by stock analysts at Fundamental Research in a research note issued to investors on Tuesday, BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Fundamental Research’s price target points to a potential upside of 97.56% from the stock’s current price.

The analysts wrote, “Fundamental Research Corp has issued a report entitled “One of the Most Undervalued Uranium Juniors in Our List” and dated April 13, 2022. The full report is now at www.researchfrc.com.”

Shares of GXU stock traded down C$0.05 on Tuesday, hitting C$0.41. The stock had a trading volume of 1,190,429 shares, compared to its average volume of 1,049,847. The firm has a market capitalization of C$223.51 million and a price-to-earnings ratio of -20.00. The stock’s 50 day moving average is C$0.41 and its 200-day moving average is C$0.39. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.03 and a current ratio of 1.04. GoviEx Uranium has a 52-week low of C$0.19 and a 52-week high of C$0.59.

In related news, Director I. Rodrigo A. Romo sold 80,500 shares of the company’s stock in a transaction on Thursday, March 10th. The shares were sold at an average price of C$0.45, for a total value of C$36,225.00. Following the sale, the director now directly owns 329,500 shares of the company’s stock, valued at C$148,275.

About GoviEx Uranium (Get Rating)

GoviEx Uranium Inc, a mineral resources company, engages in the acquisition, exploration, and development of uranium projects in Africa. The company's flagship property is the Madaouela project located in north-central Niger. It also owns 100% interest in the Mutanga project that consists of 3 mine permits situated to the south of Lusaka, Zambia; and the Falea project located in Mali.

Featured Articles